Company Description
Nuwellis, Inc., a medical device company, develops, manufactures, and commercializes medical devices used in ultrafiltration therapy.
The company provides Aquadex FlexFlow and Aquadex SmartFlow systems, which are used to treat patients suffering from fluid overload due to heart failure.
Its Aquadex FlexFlow system includes a console, disposable blood circuit set, and disposable catheter.
The company sells its products to hospitals and clinics through its direct salesforce in the United States; and through specialty healthcare distributors in Austria, Belarus, Brazil, Colombia, the Czech Republic, Germany, Greece, Hong Kong, India, Indonesia, Israel, Italy, Panama, Romania, Singapore, Slovakia, Spain, Switzerland, Thailand, the United Arab Emirates, and the United Kingdom.
The company was formerly known as CHF Solutions, Inc. and changed its name to Nuwellis, Inc. in April 2021.
Nuwellis, Inc. was founded in 1999 and is headquartered in Eden Prairie, Minnesota.
| Country | United States |
| Founded | 1999 |
| Industry | Medical Devices |
| Sector | Healthcare |
| Employees | 38 |
| CEO | John Erb |
Contact Details
Address: 12988 Valley View Road Eden Prairie, Minnesota 55344 United States | |
| Phone | 952 345 4200 |
| Website | nuwellis.com |
Stock Details
| Ticker Symbol | NUWE |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001506492 |
| CUSIP Number | 67113Y702 |
| ISIN Number | US67113Y7022 |
| Employer ID | 68-0533453 |
| SIC Code | 3845 |
Key Executives
| Name | Position |
|---|---|
| John L. Erb | Chief Executive Officer, President and Chairman |
| Neil P. Ayotte Esq. | Senior Vice President, General Counsel, Secretary and Chief Compliance Officer |
| Carisa Schultz | Chief Financial Officer, Principal Financial Officer and Principal Accounting Officer |
| Kim Anderson | Vice President of Operations |
| David Lerner | Chief Technology Officer |
| Leah McMullen | Director of Communications |
| Betsy Riemenschneider | Vice President of Sales |
| Paul Wotta | Corporate Controller |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Apr 24, 2026 | 8-K | Current Report |
| Apr 6, 2026 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
| Apr 2, 2026 | ARS | Filing |
| Apr 2, 2026 | DEF 14A | Other definitive proxy statements |
| Apr 1, 2026 | 8-K/A | [Amend] Current report |
| Mar 27, 2026 | 8-K | Current Report |
| Mar 17, 2026 | 8-K | Current Report |
| Mar 11, 2026 | 10-K | Annual Report |
| Mar 10, 2026 | 8-K | Current Report |
| Feb 26, 2026 | 8-K | Current Report |